According to Infant Bacterial Therapeutics AB's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$11.72 Million USD a decrease over its 2022 earnings that were of -$6.48 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.